Abpro Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Abpro Holdings Inc.
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
/ 
Frequently asked questions
To buy Abpro Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Abpro Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Abpro Holdings Inc. is ABP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Abpro Holdings Inc. has its primary listing on NASDAQ. You can trade Abpro Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Abpro Holdings Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Abpro Holdings Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Abpro Holdings Inc..